Belpointe Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,935
| Closed | -$907K | – | 1269 |
|
|
2021
Q2 | $907K | Buy |
4,935
+683
| +16% | +$126K | 0.07% | 322 |
|
|
2021
Q1 | $650K | Buy |
4,252
+640
| +18% | +$97.8K | 0.06% | 343 |
|
|
2020
Q4 | $564K | Sell |
3,612
-223
| -6% | -$34.8K | 0.05% | 374 |
|
|
2020
Q3 | $439K | Buy |
3,835
+162
| +4% | +$18.5K | 0.05% | 356 |
|
|
2020
Q2 | $412K | Buy |
3,673
+361
| +11% | +$40.5K | 0.05% | 336 |
|
|
2020
Q1 | $297K | Buy |
+3,312
| New | +$297K | 0.05% | 342 |
|